Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Estimated Growth Rate for the Addictions Therapeutics Market Between 2024 and 2033?

The market size for addiction therapeutics has seen robust growth over the recent years. It is projected to rise from $6.56 billion in 2023 to $7.01 billion in 2024, with a compound annual growth rate (CAGR) of 6.8%. This past expansion can be linked to increased consumption of addictive substances like alcohol, tobacco, and drugs, heightened awareness and growing instances of substance abuse disorders, the legalization of marijuana in certain areas, and augmented funding and backing for initiatives dealing with addiction treatment.

With predictions of a robust expansion in the coming years, the market for addiction therapeutics is estimated to reach $8.83 billion by 2028, boasting a compound annual growth rate (CAGR) of 6.0%. This projected growth can be linked to several factors, such as the proliferation of drug awareness campaigns, the development of synthetic drugs and novel psychoactive substances, lifestyle changes, increasing levels of stress, an expansion in rehabilitation services, and the implementation of telehealth in addiction treatment processes. Key trends to watch during this forecast period include advancements in diagnostic technology, progress in neuroscience, strategic partnerships and collaborations among pharmaceutical entities and other stakeholders to tackle addiction issues, and the introduction of new, innovative drugs for addiction therapeutics.

Claim Your Free Sample of the Global Addictions Therapeutics Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12129&type=smp

What Are the Primary Contributors to the Growth of the addictions therapeutics Market?

The addiction therapeutics market is anticipated to benefit from the rise in alcohol consumption. Consumption of alcohol entails the intake of beverages laden with ethyl alcohol. They help mitigate the impacts of alcohol addiction that curb the consumption of alcohol for individuals through the discouragement of alcohol’s depressive effects. These therapeutics foster a balance between excitatory and inhibitory neurotransmitters such as glutamate and gamma-aminobutyric acid in a person, minimizing alcohol cravings, and lessening symptoms like insomnia, anxiety, and restlessness due to alcohol withdrawal. For example, in February 2023, Statistics Canada, a national statistical agency based in Canada reported that alcohol beverage sales amounted to $26.1 billion in the fiscal year that ended in March 31, 2022, registering a 2.4% increase from the previous year. Additionally, wine sales saw a 2.1% rise, hitting $8.1 billion during the same time. The total value of alcohol sales in 2021-2022 showed beer accounted for 34.9%, followed by wine with 31.3%, spirits with 25.8% and ciders and coolers with 8.0%. Therefore, a rise in alcohol consumption is playing a critical role in driving the addiction therapeutics market.

Which Key Segments Comprise the Addictions Therapeutics Market?

1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs

2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment

3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center

4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel

5) By Application: Public, Private, Government

What Are the Key Trends Reshaping the Addictions Therapeutics Market?

Top businesses in the addiction therapeutics market are adopting innovative approaches such as developing drugs for cocaine use disorders (CUD) to expand their consumer base, augment their sales, and boost their revenue. CUD medications are specially fabricated to assist those wrestling with cocaine addiction or dependency. For example, in January 2023, a statement from Tempero Bio, a leading biopharmaceutical firm in the US, confirmed the approval of TMP-301 by the U.S. Food and Drug Administration (FDA). What sets TMP-301, the company’s research candidate, apart is its function as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM). The drug, designed to play a key role in the treatment of CUD, is noted for its strength, selectivity, and oral availability. These features target the reduction of heightened glutamate signaling linked with CUD.

Order Now for Fast Delivery of Your Addictions Therapeutics Market Report!

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

What Are the Top Regions Fueling Growth in the Addictions Therapeutics Market?

North America was the largest region in the addictions therapeutics market in 2023. The regions covered in the addictions therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Addictions Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the addictions therapeutics market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Addictions Therapeutics Market Include

1. Addictions Therapeutics Market Executive Summary

2. Addictions Therapeutics Market Segments

3. Addictions Therapeutics Market Size And Template Market Growth Rate

4. Key Addictions Therapeutics Market Trends

5. Major Addictions Therapeutics Market Drivers

……

25. Key Mergers And Acquisitions In The Addictions Therapeutics Market

26. Top Addictions Therapeutics Companies

27. Addictions Therapeutics Market Opportunities And Strategies

28. Addictions Therapeutics Market, Conclusions And Recommendations

29. Appendix

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: